Integral Diagnostics Limited (ASX:IDX)

Integral Diagnostics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 4, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	928	945	625	764	694	1,033
Market Cap Growth	-14.22%	51.38%	-18.29%	10.12%	-32.80%	36.04%
Enterprise Value	1,462	1,447	968	1,092	989	1,274
Last Close Price	2.49	2.51	2.57	3.09	2.80	4.61
PE Ratio	165.31	202.32	-	30.53	47.53	33.03
Forward PE	19.74	20.32	27.67	25.99	17.42	24.94
PS Ratio	1.48	1.51	1.33	1.73	1.92	2.95
PB Ratio	1.34	1.36	2.07	2.05	2.00	4.06
P/FCF Ratio	66.23	67.47	14.77	32.83	74.39	20.95
P/OCF Ratio	12.58	12.82	9.44	11.36	18.71	14.85
EV/Sales Ratio	2.33	2.31	2.06	2.48	2.74	3.63
EV/EBITDA Ratio	13.49	16.82	14.62	16.53	15.89	17.55
EV/EBIT Ratio	25.23	24.97	22.96	28.40	25.60	25.80
EV/FCF Ratio	104.32	103.25	22.90	46.92	105.99	25.83
Debt / Equity Ratio	0.84	0.84	1.19	0.98	0.98	1.21
Debt / EBITDA Ratio	5.40	5.40	4.27	4.45	4.53	3.66
Debt / FCF Ratio	41.75	41.75	8.46	15.68	36.55	6.25
Asset Turnover	0.58	0.58	0.60	0.55	0.50	0.56
Inventory Turnover	206.83	206.83	181.65	191.73	219.31	231.42
Quick Ratio	0.60	0.60	0.81	0.70	1.84	1.00
Current Ratio	0.68	0.68	0.87	0.76	1.93	1.06
Return on Equity (ROE)	0.97%	0.97%	-17.99%	6.95%	4.85%	12.95%
Return on Assets (ROA)	3.34%	3.34%	3.36%	2.99%	3.36%	4.97%
Return on Invested Capital (ROIC)	1.95%	2.60%	6.38%	4.95%	4.69%	7.19%
Return on Capital Employed (ROCE)	4.50%	4.50%	6.40%	5.20%	5.50%	8.60%
Earnings Yield	0.50%	0.49%	-9.72%	3.28%	2.10%	3.03%
FCF Yield	1.51%	1.48%	6.77%	3.05%	1.34%	4.77%
Dividend Yield	2.59%	2.59%	2.26%	1.94%	2.50%	2.71%
Payout Ratio	330.77%	330.77%	-	50.48%	142.87%	57.20%
Buyback Yield / Dilution	-32.86%	-32.86%	0.97%	-11.29%	-5.70%	-7.16%
Total Shareholder Return	-30.34%	-30.26%	3.23%	-9.35%	-3.20%	-4.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.